Business Standard

Wednesday, December 25, 2024 | 06:47 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Astrazeneca Pharma India reports standalone net loss of Rs 11.79 crore in the June 2024 quarter

Image

Sales rise 31.15% to Rs 387.52 crore

Net loss of Astrazeneca Pharma India reported to Rs 11.79 crore in the quarter ended June 2024 as against net profit of Rs 53.86 crore during the previous quarter ended June 2023. Sales rose 31.15% to Rs 387.52 crore in the quarter ended June 2024 as against Rs 295.47 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales387.52295.47 31 OPM %9.8222.76 -PBDT46.3175.19 -38 PBT42.4071.40 -41 NP-11.7953.86 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 08 2024 | 3:40 PM IST

Explore News